製品番号: HY-W071746

Linolelaidic acid

(別名: Linoelaidic acid)

1 Cited Publications

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

Linolelaidic acid (Linoelaidic acid) is an omega-6 trans fatty acid (TFA) that is an essential nutrient with oral activity. Linolelaidic acid can be added to enteral nutrition (oral), parenteral nutrition (intravenous), and infant formula. Linolelaidic acid has anti-inflammatory and anti-parasitic ((Parasite)) activities, and can induce Apoptosis. Linolelaidic acid is useful for research in infections.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.96%
CAS 番号: 506-21-8
分子式: C₁₈H₃₂O₂
分子量:280.45

保管条件:

Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

Linolelaidic acid 構造式

CAS 番号: 506-21-8

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Endogenous Metabolite アイソフォーム固有の製品をすべて表示 :

Parasite アイソフォーム固有の製品をすべて表示 :

体外実験

Linolenic Acid shows inhibitory activity against P. falciparum strains D10 (the chloroquine sensitive strain) and Dd2 (the chloroquine resistant strain), with IC₅₀ values of 4.12 μg/mL and 5.04 μg/mL, respectively^[2].
Linolelaidic acid (50 μM, 24 h) induces apoptosis, cell cycle arrest andinﬂammation in human umbilicalvein endothelial cells through lipid rafts^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[3]

Cell Line:

Human umbilicalvein endothelial cells (HUVECs) (Methyl-β-cyclodextrin (HY-101461)-induced lipid raft disruption model)
Concentration:

50 μM
Incubation Time:

24 h
Result:

Resulted in a significant decrease in cell viability.

Apoptosis Analysis^[3]

Cell Line:

Human umbilicalvein endothelial cells (HUVECs) (Methyl-β-cyclodextrin (HY-101461)-induced lipid raft disruption model)
Concentration:

50 μM
Incubation Time:

24 h
Result:

Resulted in a significant increase in the number of apoptotic cells and the cell population in the G1 phase.

Western Blot Analysis^[3]

Cell Line:

Human umbilicalvein endothelial cells (HUVECs) (Methyl-β-cyclodextrin (HY-101461)-induced lipid raft disruption model)
Concentration:

50 μM
Incubation Time:

24 h
Result:

Led to a significant increase in the expression levels of pro-apoptotic proteins (caspase-3, -8, Bax, p53) and inflammatory factors (vascular cell adhesion molecule-1, intercellular adhesion molecule, E-selectin, and nitric oxide), while the expression level of the anti-apoptotic protein Bcl-2 was significantly decreased.

体内実験

Linolenic Acid (10 mg/kg, p.o., once daily for 4 days) shows anti-parasitic activity in the P. berghei (ANKA) strain-induced malaria C57BL/6 mouse model^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

P. berghei (ANKA) strain-induced malaria C57BL/6 mice model (7-to-10-week old)^[3]
Dosage:

10 mg/kg
Administration:

Oral gavage (p.o.), once daily for 4 days
Result:

Inhibited the growth of P. berghei by 70%.

Animal Model:

High-fat diet-fed streptozotocin (HFD-STZ) rat model^[2]
Dosage:

500 μg/kg
Administration:

Oral gavage (p.o.), once daily for 4 weeks, 30 min myocardial ischemia followed by 4 or 6 h reperfusion after 4 weeks
Result:

Significantly improved the instantaneous first derivation of left ventricle pressure, reduced infarct size, plasma creatine kinase and lactate dehydrogenase activities, and apotosis at the end of reperfusion in HFD-STZ diabetic rats.
Not only significantly reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) concentrations but reduced the increase in superoxide production and malonaldialdehyde formation and simultaneously enhanced the antioxidant capacity in the diabetic hearts.
Increased myocardial PI3K expression and Akt phosphorylation in diabetic but not normal rats.

化学情報

CAS 番号 506-21-8
性状 Liquid (Density: 0.89 g/cm³)
分子量 280.45
分子式 C₁₈H₃₂O₂
Color Colorless to light yellow
SMILES

CCCCC/C=C/C/C=C/CCCCCCCC(O)=O
別名

Linoelaidic acid
Structure Classification
- Ketones, Aldehydes, Acids
Initial Source
- Endogenous metabolite
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Pure form	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (1)

All

Sort by:

Journal Impact Factor

Nature

Lithocholic acid phenocopies anti-ageing effects of calorie restriction. [Abstract]

2025 Jul;643(8070):192-200. PMID: 39695227

溶剤 & 溶解度

体外:

DMSO : 125 mg/mL (445.71 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.5657 mL

17.8285 mL

35.6570 mL

5 mM

0.7131 mL

3.5657 mL

7.1314 mL

10 mM

0.3566 mL

1.7828 mL

3.5657 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (274 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Jay Whelan, et al. Linoleic acid. Adv Nutr. 2013 May 1;4(3):311-2. [Content Brief]

[2]. Melariri P, et al. In vitro and in vivo antimalarial activity of linolenic and linoleic acids and their methyl esters[J]. Adv Stud Biol, 2012, 4(7): 333-49.

[3]. Li J, et al. Linolelaidic acid induces apoptosis, cell cycle arrest and inflammation stronger than elaidic acid in human umbilical vein endothelial cells through lipid rafts[J]. European Journal of Lipid Science and Technology, 2017, 119(7): 1600374.

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.5657 mL	17.8285 mL	35.6570 mL	89.1424 mL
	5 mM	0.7131 mL	3.5657 mL	7.1314 mL	17.8285 mL
	10 mM	0.3566 mL	1.7828 mL	3.5657 mL	8.9142 mL
	15 mM	0.2377 mL	1.1886 mL	2.3771 mL	5.9428 mL
	20 mM	0.1783 mL	0.8914 mL	1.7828 mL	4.4571 mL
	25 mM	0.1426 mL	0.7131 mL	1.4263 mL	3.5657 mL
	30 mM	0.1189 mL	0.5943 mL	1.1886 mL	2.9714 mL
	40 mM	0.0891 mL	0.4457 mL	0.8914 mL	2.2286 mL
	50 mM	0.0713 mL	0.3566 mL	0.7131 mL	1.7828 mL
	60 mM	0.0594 mL	0.2971 mL	0.5943 mL	1.4857 mL
	80 mM	0.0446 mL	0.2229 mL	0.4457 mL	1.1143 mL
	100 mM	0.0357 mL	0.1783 mL	0.3566 mL	0.8914 mL

Keywords

Linolelaidic acid

1 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

Linolelaidic acid

Anti-Infection Compound Library

Apoptosis Compound Library

Immunology/Inflammation Compound Library

Metabolism/Protease Compound Library

Natural Product Library

Lipid Compound Library

Medicine Food Homology Compound Library

Orally Active Compound Library

Traditional Chinese Medicine Active Compound Library

Antiparasitic Compound library

Food-Sourced Compound Library

Anti-inflammatory Traditional Chinese Medicine Active Compound Library

Human Metabolite Library

Cell Death Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Fatty Acids Compound Library

Miao Ethnicity Medicine Compound Library

Tibetan Medicine Compound Library

PBCRBS Traditional Chinese Medicine Compound Library

Heat-Clearing and Detoxification Traditional Chinese Medicine Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Mass Spectrometry Human Metabolite Library

Antitussive and Antiasthmatic Traditional Chinese Medicine Active Compound Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mongolian Medicine Compound Library

Natural Product Diversity Scaffold Library

Tonifying Traditional Chinese Medicine Monomer Compound Library

Mass Spectrometry Natural Product Library

MedChemExpress（MCE）の使用を引用している文献 Linolelaidic acid

Endogenous Metabolite アイソフォーム固有の製品をすべて表示

Parasite アイソフォーム固有の製品をすべて表示

生物活性

化学情報

Publications (1)

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Linolelaidic acid 関連分類

HY-W071746 関連分類